NCT01394471View on ClinicalTrials.gov

Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia

PHASE1CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DRUG

Intranasal Oxytocin Spray

6 insufflations (24IU of oxytocin total) given twice daily for 12 weeks

Trial Locations (1)

27599

University of North Carolina at Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of North Carolina, Chapel Hill

OTHER

NCT01394471 - Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia | Biotech Hunter | Biotech Hunter